SPRYCEL vs VONJO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. SPRYCEL and VONJO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SPRYCEL	VONJO
Rating	72/100	New
Pharmacy pays	~$839.19 /30	—
Type	RX	RX
Active ingredient	DASATINIB	PACRITINIB CITRATE
Manufacturer	Bristol Myers Squibb	Sobi
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lymphoid Leukemia, Myeloid Leukemia	Primary Myelofibrosis

sprycel vonjo

Rating

72/100

New

Pharmacy pays

~$839.19 /30

—

Type

Active ingredient

DASATINIB

PACRITINIB CITRATE

Manufacturer

Bristol Myers Squibb

Sobi

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphoid Leukemia, Myeloid Leukemia

Primary Myelofibrosis

Frequently asked questions

What is the difference between Sprycel and Vonjo?

Sprycel contains Dasatinib, while Vonjo contains Pacritinib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.